Table 4: Risk factors for omental metastasis in the Omentectomy group (N = 27).
|
|
Omental mets1 (N = 2) |
No Omental mets1 (N = 25) |
P Value |
|
Age |
76.50 |
70.08 |
0.59 |
|
BMI |
31.00 |
32.39 |
0.50 |
|
Post Op2 Grade |
|
|
1.00 |
|
Grade 3 |
2 (100%) |
23 (92%) |
|
|
Other |
0 (0%) |
2 (8%) |
|
|
Post Op Histology |
|
|
1.00 |
|
Non-endometrioid |
2 (100%) |
24 (96%) |
|
|
Endometrioid |
0 (0%) |
1 (4%) |
|
|
Stage |
|
|
0.08 |
|
Stage III/IV |
2 (100%) |
6 (24%) |
|
|
Stage I/II |
0 (0%) |
19 (76%) |
|
|
Peritoneal cytology |
|
|
0.019 |
|
Positive |
2 (100%) |
2 (8.3%) |
|
|
Negative |
0 (0%) |
22 (91.7%) |
|
|
LVI3 |
|
|
1.00 |
|
Positive |
1 (50%) |
11 (44%) |
|
|
Negative |
1 (50%) |
14 (56%) |
|
|
Size of tumor |
|
|
0.06 |
|
> 2 cm |
0 (0%) |
20 (80%) |
|
|
≤ 2 cm |
2 (100%) |
5 (20%) |
|
|
Depth of invasion |
|
|
0.54 |
|
> 50% |
0 (0%) |
9 (36%) |
|
|
≤ 50% |
2 (100%) |
16 (64%) |
|
|
LN4 Mets. |
|
|
1.00 |
|
Yes |
0 (0%) |
4 (16%) |
|
|
No |
2 (100%) |
21 (84%) |
|
|
Adnexal Mets |
|
|
0.28 |
|
Yes |
1 (50%) |
3 (12%) |
|
|
No |
1 (50%) |
22 (88%) |
|
|
CA-1255 |
|
|
0.048 |
|
> 35 |
2 (100%) |
3 (15.8%) |
|
|
≤ 35 |
0 (0%) |
16 (84.2%) |
|
1Mets: Metastasis; 2Post Op: Postoperative; 3LVI: Lymph-vascular space invasion; 4LN: Lymph node; 5CA-125: Serum CA-125